CD8A and neoplasm: In addition, among the eight patients with both baseline and longitudinal biopsies, changes in tumour-infiltrating CD8 + T cells generally (seven of eight patients) tracked with those of PD-L1 ICs (Supplemental Fig. 2), but Treg changes were more variable.